 | Up a level |
2022
Howell, C. R., Ahmed, M. W., Afanasev, A., Alesini, D., Annand, J. R. M., Aprahamian, A., Balabanski, D. L., Benson, S., V, Bernstein, A., Brune, C. R., Byrd, J., Carlsten, B. E., Champagne, A. E., Chattopadhyay, S., Davis, D., Downie, E. J., Durham, J. M., Feldman, G., Gao, H., Geddes, C. G. R., Griesshammer, H. W., Hajima, R., Hao, H., Hornidge, D., Isaak, J., Janssens, R. V. F., Kendellen, D. P., Kovash, M. A., Martel, P. P., Meissner, U-G, Miskimen, R., Pasquini, B., Phillips, D. R., Pietralla, N., Savran, D., Schindler, M. R., Sikora, M. H., Snow, W. M., Springer, R. P., Sun, C., Tang, C., Tiburzi, B., Tonchev, A. P., Tornow, W., Ur, C. A., Wang, D., Weller, H. R., Werner, V, Wu, Y. K., Yan, J., Zhao, Z., Zilges, A. and Zomer, F. (2022). International workshop on next generation gamma-ray source. J. Phys. G-Nucl. Part. Phys., 49 (1). BRISTOL: IOP Publishing Ltd. ISSN 1361-6471
2018
Hillmen, P., Soumerai, J., Zelenetz, A., Darif, M., Londhe, A., Xing, G., Huang, J., Lin, M., Byrd, J., Chanan-Khan, A., Furman, R., Hallek, M., Jones, J., Sharman, J., Ferrante, L., Reddy, V., Dreiling, L., Adewoye, H., Dubowy, R., Howes, A. and James, D. (2018). A Validated Risk Model for Overall Survival in Relapsed/Refractory Chronic Lymphocytic Leukaemia Applicable to Patients Treated with Novel Therapies and Standard of Care. Br. J. Haematol., 181. S. 75 - 76. HOBOKEN: WILEY. ISSN 1365-2141
2015
Bahlo, J., Kutsch, N., Bergmann, M., Byrd, J., Doehner, H., Eichhorst, B., Else, M., Geisler, C., Grever, M., Lepretre, S., Neuberg, D., Oscier, D., Robak, T., Rosenquist, R., Shanafelt, T., Stilgenbauer, S. and Hallek, M. (2015). THE INTERNATIONAL PROGNOSTIC INDEX FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL-IPI)-AN INTERNATIONAL META-ANALYSIS. Haematologica, 100. S. 313 - 315. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078